FDA accepted for review an sNDA for MIUDELLA copper IUD for a 6-year duration, with a PDUFA date in Q2 2027.
Related to this article
Anita Nelson, MD, discusses the FDA's approval extending etonogestrel implant use to 5 years and the new REMS certification clinicians must complete by February 23, 2027.
A new book from Sameena Rahman, MD, reclaims "brown girls' disease" as a lens for examining how dismissal—of conditions, anatomy, and patients—undermines sexual medicine care for all women.
Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.
The FDA office of Women's Health and Center for Drug Evaluation and Research and hosting a public workshop with a focus on testosterone use in menopausal women.
Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.
Atogepant reduced perimenstrual migraine days vs. placebo and met all 8 secondary endpoints in the Phase 3 LUNA study.
Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
FDA approves IDE for pivotal study of Evident ovarian cancer screening test
2
Sameena Rahman, MD, on bias, dismissed diagnoses, and the vulvar vestibule
3
Q&A: Anita Nelson, MD, on etonogestrel implant's 5-year approval and REMS certification
4
Emotional and cognitive symptoms are redefining perimenopause recognition
5